Keywords
How to Cite
Abstract
10% of patients with cancer pain who are on optimal pharmacological systemic therapy have inadequate control, explained by treatment refractoriness or intolerable adverse effects. Although interventional techniques are considered as the fourth step of the pain management ladder proposed by the World Health Organization, in cancer patients, the anticipated application of these interventional methods (such as neuroaxial analgesia and nerve blocks) can represent advantages. It is suggested a multidisciplinary approach that includes several clinical services to generate the greatest impact of this type of techniques in the treatment of cancer pain, taking into account its indications and contraindications. The analgesia via the neuroaxial route, directly directed to the spinal cord pain transmission routes, provides better control of pain, allows the reduction of analgesic doses and improves the quality of life of the patients. The choice between drug delivery systems, either implantable and external pumps depends mainly on the life expectancy of the patient
Vissers KC, Besse K, Wagemans M, Zuurmond W, Giezeman MJ, Lataster A, et al. Evidence-based interventional pain medicine. 23. Pain in patients with cancer. Pain Pr. 2011;11:453-75.
Smyth CE, Jarvis V, Poulin P. Brief review: Neuraxial analgesia in refractory malignant pain. Can J Anesth. 2014;61(2):141-53.
Jost L, Roila F. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21 Suppl 5:v257-60.
Vargas-Schaffer G. Is the WHO analgesic ladder still valid?: Twenty-four years of experience. Can Fam Physician. 2010;56(6):514-7.
Jeon YS, Lee JA, Choi JW, Kang EG, Jung HS, Kim HK, et al. Efficacy of epidural analgesia in patients with cancer pain: a retrospective observational study. Yonsei Med J. 2012;53(3):649-53.
Mella S M, Zamora P, Mella L M, Alfaro J, Uceda P. Niveles de evidencia clínica y grados de recomendación. Rev Soc Andaluza Trauma y Ortop. 2012;29(1-2):59-72.
Brown DL, Wedel DJ, Miller RD. Anestesia intradural, epidural y caudal. En: Miller RD, editor. Anestesia. Barcelona: Doyma; 1993. p. 1269-74.
Paul G, Bruce F, Robert K, Bernards CM. Chapter 25: Epidural and spinal anesthesia. Clinical Anesthesia. 2006. 1-86 p.
Teoh DA, Santosham KL, Lydell CC, Smith DF, Beriault MT. Surface anatomy as a guide to vertebral level for thoracic epidural placement. Anesth Analg. 2009;108(5):1705-7.
Reynolds F. Damage to the conus medullaris following spinal anaesthesia. Anaesthesia. 2001 Mar;56(3):238-47.
Manoj K, Vandepitte C. Introduction to ultrasound guided neuraxial and perineuraxial techniques. NYSORA [Internet]. 2013. Disponible en: http://www.nysora.com/techniques/neuraxial-and-perineuraxial-techniques/ultrasound-guided/3275-introduction.html
Tran DQH, González AP, Bernucci F, Finlayson RJ. Confirmation of loss-of-resistance for epidural analgesia. Reg Anesth Pain Med. 2015;40(2):166-73.
Stearns L, Boortz-Marx R, Du Pen S, Friehs G, Gordon M, Halyard M, et al. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. J Support Oncol. 2005;3(6):399-408.
Ruppen W, Derry S, McQuay HJ, Moore RA. Infection rates associated with epidural indwelling catheters for seven days or longer: systematic review and meta-analysis. BMC Palliat Care. 2007;6:3.
Mercadante S, Porzio G, Gebbia V. Spinal analgesia for advanced cancer patients: An update. Crit Rev Oncol/Hematol. 2011;82:227-32.
Chai T, Bruel BM, Nouri KH, Driver L. Complications after intrathecal drug delivery due to the underlying malignancy in two patients with intractable cancer pain. Pain Physician. 2013;16(2):E107-11.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.